Endothelial NOS (NOS3) impairs myocardial function in developing sepsis

Basic Research in Cardiology

Volumn 108, Issue 2, 2013, Pages

  Van De Sandt, Annette M ^a   Windler, Rainer ^a   Gödecke, Axel ^b   Ohlig, Jan ^a   Zander, Simone ^a   Reinartz, Michael ^b   Graf, Jürgen ^c,d   Van Faassen, Ernst E ^e   Rassaf, Tienush ^a   Schrader, Jürgen ^b   Kelm, Malte ^a   Merx, Marc W ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Deutsche Lufthansa AG   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Nitric oxide; NOS3; Sepsis; Septic cardiomyopathy

Indexed keywords

CATECHOLAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRATE; NITRITE; NOS3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY FLOW RESERVE; ECHOCARDIOGRAPHY; ENZYME INHIBITION; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; IN VIVO STUDY; ISOLATED HEART; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; SEPSIS; SURVIVAL RATE; WILD TYPE; ANIMAL; ARTERIAL PRESSURE; BLOOD; C57BL MOUSE; CORONARY ARTERY BLOOD FLOW; DISEASE MODEL; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; HEART FUNCTION TEST; HEMODYNAMICS; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ARTERIAL PRESSURE; CARDIAC OUTPUT; CARDIOMYOPATHIES; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEART FUNCTION TESTS; HEMODYNAMICS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; REAL-TIME POLYMERASE CHAIN REACTION; SEPSIS;

MLCS; MLOWN;

EID: 84873393773     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-013-0330-8     Document Type: Article

References (76)

1. Aird WC (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101:3765-3777. doi:10.1182/blood-2002-06-1887 (Pubitemid 36857845)
2. Balligand JL, Feron O, Dessy C (2009) eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiol Rev 89:481-534. doi:10.1152/physrev.00042.2007
3. Bougaki M, Searles RJ, Kida K, Yu J, Buys ES, Ichinose F (2010) Nos3 protects against systemic inflammation and myocardial dysfunction in murine polymicrobial sepsis. Shock 34:281-290. doi:10.1097/SHK.0b013e3181cdc327
4. Brunner F, Andrew P, Wölkert G, Zechner R, Mayer B (2001) Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation 104:3097-3102. doi:10.1161/hc5001.101966 (Pubitemid 34014064)
5. Cobb JP (2001) Nitric oxide synthase inhibition as therapy for sepsis: a decade of promise. Surg Infect 2:93-100. doi:10.1089/ 109629601750469410
6. Cobb JP, Hotchkiss R, Swanson PE et al (1999) Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. Surgery 126:438-442. pii: N9c41cb98N2a1153cc (Pubitemid 29382815)
7. Connelly L, Madhani M, Hobbs AJ (2005) Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knockout mice: a pro-inflammatory role for eNOS-derived no in vivo. J Biol Chem 280:10040-10046. doi:10.1074/jbc. M411991200 (Pubitemid 40395855)
8. Court O, Kumar A, Parrillo JE, Kumar A (2002) Clinical review: myocardial depression in sepsis and septic shock. Crit Care 6:500-508. doi:10.1186/cc1822 (Pubitemid 35414581)
9. Davis JS, Darcy CJ, Yeo TW, Jones C, McNeil YR, Stephens DP, Celermajer DS, Anstey NM (2011) Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis. PLoS ONE 6:e17260-e17260. doi:10.1371/journal.pone. 0017260
10. Doursout MF, Oguchi T, Fischer UM, Liang Y, Chelly B, Hartley CJ, Chelly JE (2008) Distribution of NOS isoforms in a porcine endotoxin shock model. Shock 29:692-702. doi:10.1097/SHK. 0b013e3181598b77 (Pubitemid 351769932)
11. Fernandes D, Sordi R, Kramer-Pacheco LK, Nardi GM, Heckert BT, Villela CG, Lobo AR, Barja-Fidalgo C, Assreuy J (2009) Late, but not early, inhibition of soluble guanylate cyclase decreases mortality in a rat sepsis model. J Pharmacol Exp Ther 328:991-999. doi:10.1124/jpet.108.142034
12. Flierl MA, Rittirsch D, Huber-Lang MS, Sarma JV, Ward PA (2008) Molecular events in the cardiomyopathy of sepsis. Mol Med 14:327-336. doi:10.2119/2007-00130.Flierl (Pubitemid 351785706)
13. Flögel U, Decking UK, Gödecke A, Schrader J (1999) Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: a study in endothelial NO synthase knockout mice. J Mol Cell Cardiol 31:827-836. doi:10.1006/jmcc.1998.0921 (Pubitemid 29201552)
14. Förstermann U, Münzel T (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113:1708-1714. doi:10.1161/CIRCULATIONAHA.105.602532
15. Garlie JB, Hamid T, Gu Y, Ismahil MA, Chandrasekar B, Prabhu SD (2011) Tumor necrosis factor receptor 2 signaling limits ß-adrenergic receptor-mediated cardiac hypertrophy in vivo. Basic Res Cardiol 106:1193-1205. doi:10.1007/s00395-011-0196-6
16. Gödecke A, Decking UK, Ding Z, Hirchenhain J, Bidmon H-J, Gödecke S, Schrader J (1998) Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res 82:186-194. doi:10.1161/01.RES.82.2.186 (Pubitemid 28080101)
17. Godecke A, Heinicke T, Kamkin A, Kiseleva I, Strasser RH, Decking UK, Stumpe T, Isenberg G, Schrader J (2001) Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts. J Physiol 532:195-204. doi:10.1111/j.1469-7793. 2001.0195g.x (Pubitemid 32303282)
18. Grau M, Hendgen-Cotta UB, Brouzos P, Drexhage C, Rassaf T, Lauer T, Dejam A, Kelm M, Kleinbongard P (2007) Recent methodological advances in the analysis of nitrite in the human circulation: nitrite as a biochemical parameter of the L-arginine/ NO pathway. J Chromatogr B Analyt Technol Biomed Life Sci 851:106-123. doi:10.1016/j.jchromb.2007.02.002 (Pubitemid 46720145)
19. Guo Y, Sanganalmath SK, Wu W, Zhu X, Huang Y, Tan W, Ildstad ST, Li Q, Bolli R (2012) Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury. Basic Res Cardiol 107:253. doi:10.1007/s00395-012-0253-9
20. Hallemeesch MM, Janssen BJA, de Jonge WJ, Soeters PB, Lamers WH, Deutz NEP (2003) NO production by cNOS and iNOS reflects blood pressure changes in LPS-challenged mice. Am J Physiol Endrocrinol Metab 285:E871-E875. doi:10.1152/ ajpendo.00004.2002 (Pubitemid 37176436)
21. Handa O, Stephen J, Cepinskas G (2008) Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis. Am J Physiol Heart Circ Physiol 295:H1712-H1719. doi:10.1152/ajpheart.00476.2008
22. Hare JM, Stamler J (2005) NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest 115:509-517. doi:10.1172/JCI24459 (Pubitemid 40322220)
23. Hauser B, Bracht H, Matejovic M, Radermacher P, Venkatesh B (2005) Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies. Anesth Analg 101:488-498. doi: 10.1213/01.ANE.0000177117.80058.4D (Pubitemid 41045235)
24. Heemskerk S, Masereeuw R, Russel FG, Pickkers P (2009) Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury. Nat Rev Nephrol 5:629-640. doi:10.1038/ nrneph.2009.155
25. Heinzel FR, Gres P, Boengler K, Duschin A, Konietzka I, Rassaf T, Snedovskaya J, Meyer S, Skyschally A, Kelm M, Heusch G, Schulz R (2008) Inducible nitric oxide synthase expression and cardiomyocyte dysfunction during sustained moderate ischemia in pigs. Circ Res 103:1120-1127. doi:10.1161/CIRCRESAHA. 108.186015
26. Hendgen-Cotta U, Grau M, Rassaf T, Kelm M, Kleinbongard P (2008) Reductive gas-phase chemiluminescence and flow injection analysis for measurement of the nitric oxide pool in biological matrices. Methods Enzymol 441:295-315. doi:10.1016/ S0076-6879(08)01216-0
27. Heusch G, Post H, Michel MC, Kelm M, Schulz R (2000) Endogenous nitric oxide and myocardial adaptation to ischemia. Circ Res 87:146-152. doi:10.1161/01.RES.87.2.146 (Pubitemid 30616911)
28. Ho JT, Chapman MJ, O'Conner S, Lam S, Edwards J, Ludbrook G, Lewis JG, Torpy DJ (2010) Characteristics of plasma NOx levels in severe sepsis: high interindividual variability and correlation with illness severity, but lack of correlation with cortisol levels. Clin Endocrinol (Oxf) 73:413-420. doi:10.1111/j.1365- 2265.2010.03817.x
29. Hollenberg SM, Broussard M, Osman J, Parrillo JE (2000) Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ Res 86:774-778. doi:10.1161/01.RES.86.7.774
30. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150. doi:10.1056/NEJMra021333 (Pubitemid 36056721)
31. Ichinose F, Buys ES, Neilan TG, Furutani EM, Morgan JG, Jassal DS, Graveline AR, Searles RJ, Lim CC, Kaneki M, Picard MH, Scherrer-Crosbie M, Janssens S, Liao R, Bloch KD (2007) Cardiomyocyte- specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. Circ Res 100:130-139. doi:10.1161/01.RES.0000253888. 09574.7a (Pubitemid 46066781)
32. Kadoi Y, Goto F (2004) Selective inducible nitric oxide inhibition can restore hemodynamics, but does not improve neurological dysfunction in experimentally-induced septic shock in rats. Anesth Analg 99:212-220. doi:10.1213/01ANE.0000118111.94913.22 (Pubitemid 38808193)
33. Kelm M, Schäfer S, Dahmann R, Dolu B, Perings S, Decking U, Schrader J, Strauer BE (1997) Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation. Cardiovasc Res 36:185-194. doi:10.1016/S0008-6363 (97)00149-1 (Pubitemid 27527343)
34. Kleinbongard P, Dejam A, Lauer T, Rassaf T, Schindler A, Picker O, Scheeren T, Gödecke A, Schrader J, Schulz R, Heusch G, Schaub GA, Bryan NS, Feelisch M, Kelm M (2003) Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 35:790-796. doi:10.1016/S0891- 5849(03)00406-4 (Pubitemid 37329482)
35. Kumar A, Haery C, Parrillo JE (2001) Myocardial dysfunction in septic shock: part I. Clinical manifestation of cardiovascular dysfunction. J Cardiothorac Vasc Anesth 15:364-376. doi: 10.1053/jcan.2001.22317 (Pubitemid 32553389)
36. Kumar A, Krieger A, Symeoneides S, Kumar A, Parrillo JE (2001) Myocardial dysfunction in septic shock: part II. Role of cytokines and nitric oxide. J Cardiothorac Vasc Anesth 15:485-511. doi:10.1053/jcan.2001.25003 (Pubitemid 32756214)
37. Lange M, Connelly R, Traber DL, Hamahata A, Nakano Y, Esechie A, Jonkam C, von Borzyskowski S, Traber LD, Schmalstieg FC, Herndon DN, Enkhbaatar P (2010) Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis model. Crit Care 14:R129-R129. doi: 10.1186/cc9097
38. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman JT, Donaldson J, Arneson C, Grove G, Grossman S, Grover R (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21-30. doi:10.1097/01.CCM.0000105581.01815.C6 (Pubitemid 38125559)
39. Lupia E, Spatola T, Cuccurullo A, Bosco O, Mariano F, Pucci A, Ramella R, Alloatti G, Montrucchio G (2010) Thrombopoietin modulates cardiac contractility in vitro and contributes to myocardial depressing activity of septic shock serum. Basic Res Cardiol 105:609-620. doi:10.1007/s00395-010-0103-6
40. Martin C, Schulz R, Post H, Gres P, Heusch G (2003) Effect of NO synthase inhibition on myocardial metabolism during moderate ischemia. Am J Physiol Heart Circ Physiol 284:H2320- H2324. doi:10.1152/ajpheart.01122.2002 (Pubitemid 36622447)
41. McGown CC, Brookes ZL (2007) Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide. Br J Anaesth 98:163-175. doi:10.1093/bja/aeI358 (Pubitemid 47071995)
42. Merx MW, Flogel U, Stumpe T, Gödecke A, Decking UK, Schrader J (2001) Myoglobin facilitates oxygen diffusion. FASEB J 15:1077-1079. doi:10.1096/fj.00-0497fje
43. Merx MW, Liehn EA, Graf J, van de Sandt A, Schaltenbrand M, Schrader J, Hanrath P, Weber C (2005) Statin treatment after onset of sepsis in a murine model improves survival. Circulation 112:117-124. doi:10.1161/CIRCULATIONAHA. 104.502195 (Pubitemid 40962577)
44. Merx MW, Liehn EA, Janssens U, Lütticken R, Schrader J, Hanrath P, Weber C (2004) HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation 109:2560-2565. doi:10.1161/01.CIR.0000129 774.09737.5B (Pubitemid 38720557)
45. Merx MW, Weber C (2007) Sepsis and the heart. Circulation 116:793-802. doi:10.1161/CIRCULATIONAHA.106.678359 (Pubitemid 47255997)
46. Mozaffari MS, Baban B, Liu JY, Abebe W, Sullivan JC, El-Marakby A (2011) Mitochondrial complex I and NAD(P)H oxidase are major sources of exacerbated oxidative stress in pressure-overloaded ischemic-reperfused hearts. Basic Res Cardiol 106:287-297. doi:10.1007/s00395-011-0150-7
47. Nussler AK, Bruckner UB, Vogt J, Radermacher P (2002) Measuring end products of nitric oxide in vivo. Methods Enyzmol 359:75-83. doi:10.1016/S0076-6879(02)59173-4 (Pubitemid 35387011)
48. Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471-1477. doi:10.1056/NEJM199305203282008 (Pubitemid 23143850)
49. Post H, Schulz R, Gres P, Heusch G (2001) No involvement of nitric oxide in the limitation of beta -adrenergic inotropic responsiveness during ischemia. Am J Physiol Heart Circ Physiol 281:H2392-H2397
50. Preiser JC, Zhang H, Vray B, Hrabak A, Vincent JL (2001) Time course of inducible nitric oxide synthase activity following endotoxin administration in dogs. Nitric Oxide 5:208-211. doi: 10.1006/niox.2001.0342 (Pubitemid 34142744)
51. Rassaf T, Bryan NS, Kelm M, Feelisch M (2002) Concomitant presence of N-nitroso and S-nitroso proteins in human plasma. Free Radic Biol Med 33:1590-1596. doi:10.1016/S0891-5849 (02)01183-8 (Pubitemid 35355729)
52. Rassaf T, Feelisch M, Kelm M (2004) Circulating NO pool: assessment of nitrite and nitroso species in blood and tissues. Free Radic Biol Med 36:413-422. doi:10.1016/j.freeradbiomed.2003. 11.011 (Pubitemid 38224513)
53. Rassaf T, Poll LW, Brouzos P, Lauer T, Totzeck M, Kleinbongard P, Gharini P, Andersen K, Schulz R, Heusch G, Mödder U, Kelm M (2006) Positive effects of nitric oxide on left ventricular function in humans. Eur Heart J 27:1699-1705. doi:10.1093/ eurheartj/ehl096 (Pubitemid 44025358)
54. Reinartz M, Molojavyi A, Moellendorf S, Hohlfeld T, Heger J, Gödecke A (2011) ß-Adrenergic signaling and response to pressure overload in transgenic mice with cardiac-specific overexpression of inducible NO synthase. Nitric Oxide 25:11-21. doi: 10.1016/j.niox.2011.04.001
55. Reinartz M, Ding Z, Flögel U, Gödecke A, Schrader J (2008) Nitrosative stress leads to protein glutathiolation, increased S-nitrosation and up-regulation of peroxiredoxins in the heart. J Biol Chem 283:17440-17449
56. Rudiger A, Singer M (2007) Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35:1599-1608. doi:10.1097/01. CCM.0000266683.64081.02
57. Schulz R, Dodge KL, Lopaschuk GD, Clanachan AS (1997) Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency. Am J Physiol 272:H1212-H1219
58. Schulz R, Kelm M, Heusch G (2004) Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 61:402-413. doi: 10.1016/j.cardiores.2003.09.019 (Pubitemid 38210147)
59. Sirker A, Zhang M, Shah AM (2011) NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res Cardiol 106:735-747. doi:10.1007/s00395- 011-0190-z
60. Staehr M, Madsen K, Vanhoutte PM, Hansen PB, Jensen BL (2011) Disruption of COX-2 and eNOS does not confer protection from cardiovascular failure in lipopolysaccharide-treated conscious mice and isolated vascular rings. Am J Physiol Regul Integr Comp Physiol 301:R412-R420. doi:10.1152/ajpregu.00823.2010
61. Stein B, Eschenhagen T, Rüdiger J, Scholz H, Förstermann U, Gath I (1998) Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure. J Am Coll Cardiol 32:1179-1186. doi:10.1016/ S0735-1097(98)00399-4 (Pubitemid 28522371)
62. Strunk V, Hahnenkamp K, Schneuing M, Fischer LG, Rich GF (2001) Selective iNOS inhibition prevents hypotension in septic rats while preserving endothelium-dependent vasodilation. Anesth Analg 92:681-687 (Pubitemid 32185112)
63. Szelid Z, Pokreisz P, Liu X, Vermeersch P, Marsboom G, Gillijns H, Pellens M, Verbeken E, van de Werf F, Collen D, Janssens SP (2010) Cardioselective nitric oxide synthase 3 gene transfer protects against myocardial reperfusion injury. Basic Res Cardiol 105:169-179. doi:10.1007/s00395-009-0077-4
64. Tavener SA, Kubes P (2006) Cellular and molecular mechanisms underlying LPS-associated myocyte impairment. Am J Physiol Heart Circ Physiol 290:H800-H806. doi:10.1152/ajpheart.00701. 2005
65. Teng RJ, Wu TJ, Bisig CG, Eis A, Pritchard KA, Konduri GG (2011) Nitrotyrosine impairs angiogenesis and uncouples eNOS activity of pulmonary artery endothelial cells isolated from developing sheep lungs. Pediatr Res 69:112-117
66. Thielmann M, Dörge H, Martin C, Belosjorow S, Schwanke U, van de Sand A, Konietzka I, Büchert A, Krüger A, Schulz R, Heusch G (2002) Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-a, and sphingosine. Circ Res 90:807-813. doi:10.1161/01.RES.0000014451.75415.36 (Pubitemid 34633897)
67. Thiemermann C, Szabó C, Mitchell JA, Vane JR (1993) Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA 90:267-271 (Pubitemid 23010291)
68. Tiede K, Melchior-Becker A, Fischer JW (2010) Transcriptional and posttranscriptional regulators of biglycan in cardiac fibroblasts. Basic Res Cardiol 105:99-108. doi:10.1007/s00395-009- 0049-8
69. van Faassen EE (2007) Radicals for life: the various forms of nitric oxide. Part V, pp 381-406. ISBN: 9780444522368
70. van Faassen EE, Koeners MP, Joles JA, Vanin AF (2008) Detection of basal NO production in rat tissues using iron-dithiocarbamate complexes. Nitric Oxide 18:279-286. doi:10.1016/j.niox. 2008.02.003
71. Vanin AF, Bevers LM, Mikoyan VD, Poltorakov AP, Kubrina LN, Van Faassen E (2007) Reduction enhances yields of nitric oxide trapping by iron-diethyldithiocarbamate complex in biological systems. Nitric Oxide 16:71-81. doi:10.1016/j.niox.2006. 06.009 (Pubitemid 44820885)
72. Vo PA, Lad B, Tomlinson JAP, Francis S, Ahluwalia A (2005) Autoregulatory role of endothelium-derived nitric oxide (NO) on Lipopolysaccharide-induced vascular inducible NO synthase expression and function. J Biol Chem 280:7236-7243 (Pubitemid 40341281)
73. Wei XQ, Charles IG, Smith A, Ure J, Feng CJ, Huang FP, Xu DM, Muller W, Moncada S, Liew FY (1995) Altered immuneresponses in mice lacking inducible nitric-oxide synthase. Nature 375:408-411. doi:10.1038/375408a0
74. Zhang T, Feng Q (2010) Nitric oxide and calcium signaling regulate myocardial tumor necrosis factor-alpha expression and cardiac function in sepsis. Can J Physiol Pharmacol 88:92-104. doi:10.1139/Y09-097
75. Zhang T, Lu X, Li J, Chidiac P, Sims SM, Feng Q (2012) Inhibition of Na/K-ATPase promotes myocardial tumor necrosis factor-alpha protein expression and cardiac dysfunction via calcium/ mTOR signaling in endotoxemia. Basic Res Cardiol 107:254. doi:10.1007/s00395-012-0254-8
76. Zhang YS, He L, Liu B, Li NS, Luo XJ, Hu CP, Ma QL, Zhang GG, Li YJ, Peng J (2012) A novel pathway of NADPH oxidase/ vascular peroxidase 1 in mediating oxidative injury following ischemia-reperfusion. Basic Res Cardiol 107:266. doi:10.1007/ s00395-012-0266-4